Registration Dossier

Administrative data

Key value for chemical safety assessment

Effects on fertility

Description of key information

The study does not need to be conducted because relevant human exposure can be excluded as demonstrated in the relevant exposure assessment

Link to relevant study records
Reference
Endpoint:
screening for reproductive / developmental toxicity
Data waiving:
exposure considerations
Justification for data waiving:
the study does not need to be conducted because relevant human exposure can be excluded as demonstrated in the relevant exposure assessment
Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available

Effects on developmental toxicity

Description of key information

The study does not need to be conducted because relevant human exposure can be excluded as demonstrated in the relevant exposure assessment.

 

Additionally, supporting studies with the read-across substance cumene demonstrate that 1,3,5-triisopropylbenzene is not teratogenic.

Effect on developmental toxicity: via oral route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no adverse effect observed
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available

Justification for classification or non-classification

Supporting studies with the read-across substance cumene demonstrate that 1,3,5-triisopropylbenzene is not teratogenic.

Therefore, the test substance does not meet the EC 1278/2008 as amended criteria for classification for reproductive toxicity.